GleanMark is free for all of AprilGet free access
Ride Therapeutics, Inc. logo

Ride Therapeutics, Inc.

3 Marks
Corp.
First Filed:Jan 10, 2024Latest Filed:Jan 10, 2024Address:One Mifflin Place, Cambridge, MA 02138

Portfolio Overview

Pending
3(100%)

Top Classes

Class 42
Software, IT Services & Scientific Research
3(100%)

TTAB Proceedings

No litigation activity

Top Firms

WYRICK ROBBINS YATES & PONTO...(Jan 2024)
3

Trademark Portfolio

3 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
RIDE THERAPEUTICS
RIDE THERAPEUTICS
Service Mark
Word
ITU
PENDING
Owner:
Serial:98351762
Filed:Jan 10, 2024
Classes:42
Goods & Services
"THERAPEUTICS"; Medical and scientific research services; Research and development of drug delivery platforms; Research and development in the field of technology and micro- and nano-engineering, namely, development of drug delivery agents for use in pharmaceutical and biomedical industry; Development of new technology for others for enabling the engineering and modification of mRNA and genes for the purpose of developing molecular and cellular drug delivery agents for use in pharmaceutical and biomedical industry
RIDE THERAPEUTICS THE MOLECULAR LOGISTICS COMPANY
Owner:
Serial:98351758
Filed:Jan 10, 2024
Classes:42
Goods & Services
"THERAPEUTICS" and "THE MOLECULAR LOGISTICS COMPANY"; Medical and scientific research services; Research and development of drug delivery platforms; Research and development in the field of technology and micro- and nano-engineering, namely, development of drug delivery agents for use in pharmaceutical and biomedical industry; Development of new technology for others for enabling the engineering and modification of mRNA and genes for the purpose of developing molecular and cellular drug delivery agents for use in pharmaceutical and biomedical industry
THE MOLECULAR LOGISTICS COMPANY
PENDING
Owner:
Serial:98351754
Filed:Jan 10, 2024
Classes:42
Goods & Services
"COMPANY"; Medical and scientific research services; Research and development of drug delivery platforms; Research and development in the field of technology and micro- and nano-engineering, namely, development of drug delivery agents for use in pharmaceutical and biomedical industry; Development of new technology for others for enabling the engineering and modification of mRNA and genes for the purpose of developing molecular and cellular drug delivery agents for use in pharmaceutical and biomedical industry

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.